|
1
|
Reddy K, Ooms M, Letko M, Garrett N, Simon
V and Ndung'u T: Functional characterization of Vif proteins from
HIV-1 infected patients with different APOBEC3G haplotypes. AIDS.
30:1723–1729. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Bertine M, Charpentier C, Visseaux B,
Storto A, Collin G, Larrouy L, Damond F, Matheron S, Brun-Vézinet F
and Descamps D; ANRS CO5 HIV-2 Cohort, : High level of APOBEC3F/3G
editing in HIV-2 DNA vif and pol sequences from
antiretroviral-naive patients. AIDS. 29:779–784. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Merindol N and Berthoux L: Restriction
factors in HIV-1 disease progression. Curr HIV Res. 13:448–461.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Nakayama EE and Shioda T: Impact of
TRIM5alpha in vivo. AIDS. 29:1733–1743. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Li SX, Barrett BS, Guo K and Santiago ML:
Tetherin/BST-2: Restriction factor or immunomodulator? Curr HIV
Res. 14:235–246. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Lahouassa H, Daddacha W, Hofmann H, Ayinde
D, Logue EC, Dragin L, Bloch N, Maudet C, Bertrand M, Gramberg T,
et al: SAMHD1 restricts the replication of human immunodeficiency
virus type 1 by depleting the intracellular pool of deoxynucleoside
triphosphates. Nat Immunol. 13:223–228. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
St Gelais C and Wu L: SAMHD1: A new
insight into HIV-1 restriction in myeloid cells. Retrovirology.
8:552011. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Jermy A: Viral infection: SAMHD1 cuts the
power to HIV-1. Nat Rev Microbiol. 10:2372012. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Laguette N and Benkirane M: How SAMHD1
changes our view of viral restriction. Trends Immunol. 33:26–33.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Kang J, Hou J, Zhao K, Yu XF and Du J: HD
domain of SAMHD1 influences Vpx-induced degradation at a
post-interaction step. Biochem Biophys Res Commun. 470:690–696.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Powell RD, Holland PJ, Hollis T and
Perrino FW: Aicardi-Goutieres syndrome gene and HIV-1 restriction
factor SAMHD1 is a dGTP-regulated deoxynucleotide
triphosphohydrolase. J Biol Chem. 286:43596–43600. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Riveira-Muñoz E, Ruiz A, Pauls E,
Permanyer M, Badia R, Mothe B, Crespo M, Clotet B, Brander C,
Ballana E and Esté JA: Increased expression of SAMHD1 in a subset
of HIV-1 elite controllers. J Antimicrob Chemother. 69:3057–3060.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Gonzalez SM, Taborda NA, Feria MG, Arcia
D, Aguilar-Jiménez W, Zapata W and Rugeles MT: High expression of
antiviral proteins in mucosa from individuals exhibiting resistance
to human immunodeficiency virus. PLoS One. 10:e01311392015.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Santos ÍM, da Rosa EA, Gräf T, Ferreira
LG, Petry A, Cavalheiro F, Reiche EM, Zanetti CR and Pinto AR:
Analysis of immunological, viral, genetic, and environmental
factors that might be associated with decreased susceptibility to
HIV infection in serodiscordant couples in florianopolis, Southern
Brazil. AIDS Res Hum Retroviruses. 31:1116–1125. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Jin C, Peng X, Liu F, Cheng L, Lu X, Yao
H, Wu H and Wu N: MicroRNA-181 expression regulates specific
post-transcriptional level of SAMHD1 expression in vitro. Biochem
Biophys Res Commun. 452:760–767. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Khopkar P, Mallav V, Chidrawar S and
Kulkarni S: Comparative evaluation of the Abbott HIV-1 RealTime™
assay with the standard Roche COBAS® Amplicor™ HIV-1
Monitor® Test, v1.5 for determining HIV-1 RNA levels in
plasma specimens from Pune, India. J Virol Methods. 191:82–87.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Shmagel KV, Saidakova EV, Shmagel NG,
Korolevskaya LB, Chereshnev VA, Robinson J, Grivel JC, Douek DC,
Margolis L, Anthony DD and Lederman MM: Systemic inflammation and
liver damage in HIV/hepatitis C virus coinfection. HIV Med.
17:581–589. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Nguyen TP, Shukla S, Asaad R, Freeman ML,
Lederman MM, Harding CV and Sieg S: Responsiveness to IL-7 but not
to IFN-alpha is diminished in CD4+ T cells from treated HIV
infected patients who experience poor CD4+ T-cell recovery. AIDS.
30:2033–2042. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Jin C, Ji S, Xie T, Höxtermann S, Fuchs W,
Lu X, Wu H, Cheng L, Skaletz-Rorowski A, Brockmeyer NH and Wu N:
Severe dyslipidemia and immune activation in HIV patients with
dysglycemia. HIV Clin Trials. 17:189–196. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Ruffin N, Brezar V, Ayinde D, Lefebvre C,
Schulze Zur, Wiesch J, van Lunzen J, Bockhorn M, Schwartz O, Hocini
H, et al: Low SAMHD1 expression following T-cell activation and
proliferation renders CD4+ T cells susceptible to HIV-1. AIDS.
29:519–530. 2015.PubMed/NCBI
|
|
22
|
Hrecka K, Hao C, Gierszewska M, Swanson
SK, Kesik-Brodacka M, Srivastava S, Florens L, Washburn MP and
Skowronski J: Vpx relieves inhibition of HIV-1 infection of
macrophages mediated by the SAMHD1 protein. Nature. 474:658–661.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Baldauf HM, Pan X, Erikson E, Schmidt S,
Daddacha W, Burggraf M, Schenkova K, Ambiel I, Wabnitz G, Gramberg
T, et al: SAMHD1 restricts HIV-1 infection in resting CD4(+) T
cells. Nat Med. 18:1682–1687. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Wu L: SAMHD1: A new contributor to HIV-1
restriction in resting CD4+ T-cells. Retrovirology. 9:882012.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Laguette N, Sobhian B, Casartelli N,
Ringeard M, Chable-Bessia C, Ségéral E, Yatim A, Emiliani S,
Schwartz O and Benkirane M: SAMHD1 is the dendritic- and
myeloid-cell-specific HIV-1 restriction factor counteracted by Vpx.
Nature. 474:654–657. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Jin C, Peng X, Liu F, Cheng L, Xie T, Lu
X, Wu H and Wu N: Interferon-induced sterile alpha motif and
histidine/aspartic acid domain-containing protein 1 expression in
astrocytes and microglia is mediated by microRNA-181a. AIDS.
30:2053–2064. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Jin C, Zhang F, Wu L, Xie T, Cheng Y, Tang
Z and Wu N: Immune activation and CD127 expression on T lymphocyte
subsets of a Chinese cohort of pediatric AIDS patients with
different viral responses. Curr HIV Res. 10:584–591. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Jin C, Cheng L, Hoxtermann S, Höxtermann
S, Xie T, Lu X, Wu H, Skaletz-Rorowski A, Brockmeyer NH and Wu N:
MicroRNA-155 is a biomarker of T-cell activation and immune
dysfunction in HIV-1-infected patients. HIV Med. 18:354–362. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Rice GI, Bond J, Asipu A, Brunette RL,
Manfield IW, Carr IM, Fuller JC, Jackson RM, Lamb T, Briggs TA, et
al: Mutations involved in Aicardi-Goutières syndrome implicate
SAMHD1 as regulator of the innate immune response. Nat Genet.
41:829–832. 2009. View
Article : Google Scholar : PubMed/NCBI
|
|
30
|
Kim B, Nguyen LA, Daddacha W and
Hollenbaugh JA: Tight interplay among SAMHD1 protein level,
cellular dNTP levels, and HIV-1 proviral DNA synthesis kinetics in
human primary monocyte-derived macrophages. J Biol Chem.
287:21570–21574. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Kiselinova M, De Spiegelaere W, Buzon MJ,
Malatinkova E, Lichterfeld M and Vandekerckhove L: Integrated and
total HIV-1 DNA predict ex vivo viral outgrowth. PLoS Pathog.
12:e10054722016. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Williams JP, Hurst J, Stöhr W, Robinson N,
Brown H, Fisher M, Kinloch S, Cooper D, Schechter M, Tambussi G, et
al: HIV-1 DNA predicts disease progression and post-treatment
virological control. Elife. 3:e038212014. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Welbourn S, Dutta SM, Semmes OJ and
Strebel K: Restriction of virus infection but not catalytic dNTPase
activity is regulated by phosphorylation of SAMHD1. J Virol.
87:11516–11524. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Weiss L, Chevalier MF, Assoumou L, Didier
C, Girard PM, Piketty C, Costagliola D and Rouzioux C; ANRS 116
SALTO Study Group, : T-cell activation positively correlates with
cell-associated HIV-DNA level in viremic patients with primary or
chronic HIV-1 infection. AIDS. 28:1683–1687. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Geretti AM, Arribas JR, Lathouwers E,
Foster GM, Yakoob R, Kinloch S, Hill A, van Delft Y and
Moecklinghoff C: Dynamics of cellular HIV-1 DNA levels over 144
weeks of darunavir/ritonavir monotherapy versus triple therapy in
the MONET trial. HIV Clin Trials. 14:45–50. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Cuzin L, Pugliese P, Sauné K, Allavena C,
Ghosn J, Cottalorda J, Rodallec A, Chaix ML, Fafi-Kremer S, Soulié
C, et al: Levels of intracellular HIV-DNA in patients with
suppressive antiretroviral therapy. AIDS. 29:1665–1671. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Maelfait J, Bridgeman A, Benlahrech A,
Cursi C and Rehwinkel J: Restriction by SAMHD1 limits
cGAS/STING-dependent innate and adaptive immune responses to HIV-1.
Cell Rep. 16:1492–1501. 2016. View Article : Google Scholar : PubMed/NCBI
|
